Fernandes Natasha 4
4 · IMAX CORP · Filed Nov 24, 2025
Insider Transaction Report
Form 4
IMAX CORPIMAX
Fernandes Natasha
Chief Financial Officer & EVP
Transactions
- Conversion
common shares
2025-11-24$22.49/sh+2,652$59,643→ 33,909 total - Conversion
stock options (to buy)
2025-11-24$22.49/sh−2,652$59,643→ 0 totalExercise: $22.49Exp: 2026-03-07→ common shares (2,652 underlying) - Sale
common shares
2025-11-24$36.15/sh−2,652$95,864→ 31,257 total
Holdings
- 31,257
common shares (opening balance)
Footnotes (4)
- [F1]Represents the conversion upon exercise of stock options into common shares.
- [F2]These options were issued in 2019 and are set to expire on March 7, 2026.
- [F3]The stock options became exercisable in four installments: 530 on March 7, 2020, 663 on each of March 7, 2021 and March 7, 2022 and 796 on March 7, 2023.
- [F4]This represents the number of stock options for this transaction only. Ms. Fernandes' aggregate remaining outstanding restricted share unit and common share balances following these transactions will be 39,734 and 31,257, respectively.